We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCLS
13501
Q/C Technologies Inc
QCLS
$21.8M
$11.1K ﹤0.01%
3
-11
-79% -$69.1K
ONCT
13502
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$11.1K ﹤0.01%
555
-135
-20% -$2.69K
ZYNE
13503
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$11.1K ﹤0.01%
20,900
-16,200
-44% -$10.3K
EPHY
13504
CALL
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$11K ﹤0.01%
+1,100
New +$11K
PUK icon
13505
PUT
Prudential
PUK
$34.7B
$11K ﹤0.01%
+400
New +$9.14K
AKBA icon
13506
PUT
Akebia Therapeutics
AKBA
$242M
$11K ﹤0.01%
19,000
-13,500
-42% -$4.23K
BPT
13507
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$10.9K ﹤0.01%
+937
New +$12.2K
BKD icon
13508
CALL
Brookdale Senior Living
BKD
$3.02B
$10.9K ﹤0.01%
+4,000
New +$15K
MTUS icon
13509
PUT
Metallus
MTUS
$904M
$10.9K ﹤0.01%
+600
New +$10.6K
FCUV icon
13510
PUT
Focus Universal
FCUV
$3.95M
$10.9K ﹤0.01%
6
-223
-97% -$578K
CSII
13511
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
$10.9K ﹤0.01%
+800
New +$11.1K
FURY
13512
Fury Gold Mines
FURY
$117M
$10.9K ﹤0.01%
+25,523
New +$9.55K
IFRA icon
13513
PUT
iShares US Infrastructure ETF
IFRA
$4.66B
$10.9K ﹤0.01%
+300
New +$10.7K
FXH icon
13514
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$10.9K ﹤0.01%
100
-7,300
-99% -$765K
UAMY icon
13515
PUT
United States Antimony
UAMY
$825M
$10.8K ﹤0.01%
22,200
+1,800
+9% +$697
CZOO
13516
PUT
DELISTED
Cazoo Group Ltd
CZOO
$10.7K ﹤0.01%
34
+12
+55% +$7.11K
NMG
13517
CALL
Nouveau Monde Graphite
NMG
$484M
$10.7K ﹤0.01%
+2,800
New +$13.2K
SIEB icon
13518
CALL
Siebert Financial
SIEB
$78.9M
$10.7K ﹤0.01%
7,900
-26,300
-77% -$41.8K
KOPN icon
13519
PUT
Kopin
KOPN
$1.02B
$10.7K ﹤0.01%
+8,600
New +$10.6K
VATE icon
13520
PUT
INNOVATE Corp
VATE
$109M
$10.7K ﹤0.01%
+570
New +$6.01K
GLUE icon
13521
PUT
Monte Rosa Therapeutics
GLUE
$1.32B
$10.7K ﹤0.01%
+1,400
New +$11.7K
NUVB.WS
13522
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$10.7K ﹤0.01%
73,722
+296
+0.4% +$40
NM
13523
DELISTED
Navios Maritime Holdings Inc.
NM
$10.6K ﹤0.01%
+6,080
New +$11.7K
FTHM icon
13524
PUT
Fathom Holdings
FTHM
$25.7M
$10.6K ﹤0.01%
2,500
-20,200
-89% -$95.4K
SRCE icon
13525
PUT
1st Source
SRCE
$2.13B
$10.6K ﹤0.01%
+200
New +$10.9K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.